The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 1, 1999, Pages 85-91

  Mathiesen, Ulrik L ^a,b,c   Franzen L E ^a,b,c   Fryden A ^a,b,c   Foberg, U ^a,b,c   Bodemar, G ^a,b,c  

^a Department of Internal Medicine   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Asymptomatic; Chronic hepatitis; Cryptogen; Interface hepatitis; Liver biopsy; Non alcoholic steatohepatitis; Steatosis; Transaminitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 1 ANTITRYPSIN; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; MALE; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ALPHA 1-ANTITRYPSIN DEFICIENCY; ASPARTATE AMINOTRANSFERASES; AUTOANTIBODIES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HEPATITIS, ALCOHOLIC; HEPATITIS, AUTOIMMUNE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES; MALE;

EID: 0033008248     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529950172880     Document Type: Article

References (16)

1. 1. Levine RA, Ranek L. Asymptomatic chronic hepatitis. Gastroenterology 1970;58:371-8.
2. 2. Hultcrantz R, Glauman H, Lindberg G, H-son Nilsson L. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109-13.
3. 3. Van Ness MM, Diehl AM. Is liver biopsy useful in the evaluation of patients with elevated liver enzymes? Ann Intern Med 1989;11:473-8.
4. 4. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989;9: 193-7.
5. 5. Sherlock S. Needle biopsy of the liver. In: Sherlock S, Dooley J, editors. Diseases of the liver and biliary system. Oxford: Blackwell; 1993. p. 33-43.
6. 6. MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 2nd ed. Edinburgh: Churchill Livingstone; 1987.
7. 7. Ludwig J. Practical liver biopsy interpretation - diagnostic algorithms. Chicago: ASCP Press; 1992.
8. 8. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
9. 9. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995;21:1725-41.
10. 10. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
11. 11. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
12. 12. Joint FAO/WHO/UNU Expert consultation report. Energy and protein requirements. Geneva: WHO; 1985. Technical Report Series 724 1985.
13. 13. Sherlock S. Alcoholic liver disease. Lancet 1994;345:227-9.
14. 14. Individuella skydds- och skadeeffekter av alkohol. State of the art document. Stockholm: Swedish Medical Research Council; 1997.
15. 15. Mathiesen UL, Karlsson E, Foberg U, Frydén A, Franzén L, Widell A, et al. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery. Scand J Gastroenterol. 1993;28:581-4.
16. 16. Johnson P, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.